1. HBW Insight
  2. >>Health
  3. >>Rx-to-OTC Switch

Stada Blasts German Sleep Aid Reverse Switch

 
• By David Ridley

Stada criticizes German switch committee's recommendation to restrict access to first generation antihistamines with a sedative effect for over-65s. 

Elderly_Sleep_Problems
• Source: Shutterstock

Stada Arzneimittel AG has criticized a decision by the Germany's Expert Committee for Prescription (SVA) to restrict access to sedative antihistamines for elderly consumers.

At its recent meeting, the SVA by majority recommended the OTC-to-prescription reverse-switch of both diphenhydramine and doxylamine for the treatment...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Rx-to-OTC Switch

More from Health

Softness In US And China Holds Back Bayer Consumer Health

 
• By Tom Gallen

Like its peers, Bayer Consumer Health has struggled in the challenging US market in the first half of 2025 and says it doesn't expect conditions to change this year.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

 
• By Malcolm Spicer

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.

Recordati Benefits From Cough & Cold Rebound

 
• By Tom Gallen

OTC sales grew at Italy's Recordati in the first half of 2025, with an improving cough and cold picture contributing to the rise.